High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$362K
$362,130
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
ELVN
S
Enliven Therapeutics, Inc.
Hohl Benjamin
• CFO
Discretionary SellΔOwn -16.4%
2026-03-06
$295,839
|
||||||
| ELVN |
Enliven Therapeutics, Inc.
|
CFO
Discretionary SellΔOwn -16.4%
|
2026-03-06 | $295,839 | S | Form 4 |
| ELVN |
Enliven Therapeutics, Inc.
|
CFO
Other
|
2025-12-22 | $32,240 | M | Form 4 |
| ELVN |
Enliven Therapeutics, Inc.
|
CFO
Equity Compensation
|
2025-12-22 | $0 | M | Form 4 |
| ELVN |
Enliven Therapeutics, Inc.
|
CFO
Other
|
2025-09-29 | $8,060 | M | Form 4 |
| ELVN |
Enliven Therapeutics, Inc.
|
CFO
10b5-1 SellΔOwn -12.4%
|
2025-09-29 | $66,291 | S | Form 4 |